홈 › 비소세포폐암 › 일리노이

일리노이의 비소세포폐암 임상 시험

비소세포폐암 관련 연구 91개가 일리노이 내 여러 지역에서 참여자를 모집하고 있습니다.

일리노이의 도시

공식 연구 텍스트(영어)

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

University of Illinois Chicago, Chicago
Illinois Cancer Specialists, Niles

피험자 모집 중3상

18세 ~ 100세 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT05920356

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer

University of Chicago, Chicago

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT07659782

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-based Chemotherapy With or Without Amivantamab for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

Rush University Medical Center, Chicago

피험자 모집 중2/3상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07100080

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Endeavor Health, Elmhurst
Hope and Healing Cancer Services, Hinsdale
Advocate Medical Group - Libertyville Oncology, Libertyville
외 4개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06758401

A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)

Duly Healthcare ( Site 0158), Lisle

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07554339

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Northwestern University, Chicago
Northwestern Medicine Cancer Center Kishwaukee, DeKalb
Northwestern Medicine Cancer Center Delnor, Geneva
외 8개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06498635

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Advocate Good Shepherd Hospital, Barrington
Illinois CancerCare-Bloomington, Bloomington
Illinois CancerCare-Canton, Canton
외 42개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT04267848

A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

Orchard Healthcare Research Inc. ( Site 0115), Skokie

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06345729

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

University of Illinois Cancer Center, Chicago

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06472245

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

North Shore University Health System ( Site 4014), Evanston
Accellacare of Duly ( Site 4005), Lisle

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT06312137

Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)

Local Institution - 0185, Chicago
Local Institution - 0207, Ottawa

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT07680790

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

Research Site, Chicago
Research Site, Chicago
Research Site, Hinsdale
외 2개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT07291037

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

Northwest Oncology & Hematology, Barrington
Elmhurst Hospital Nancy Knowles Cancer Center, Elmhurst
Edward Cancer Center, Naperville
외 1개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT06216301

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

The University of Chicago Medical Center ( Site 0118), Chicago
Illinois Cancer Care ( Site 8107), Peoria

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT06623422

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

Illinois Cancer Care ( Site 7000), Peoria

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT07513376

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

University of Illinois Cancer Center, Chicago

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT04198766

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Illinois Cancer Specialists, Arlington Heights
Illinois CancerCare- Bloomington, Bloomington
Illinois Cancer Specialists, Chicago
외 7개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07144280

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

Illinois CancerCare-Bloomington, Bloomington
Illinois CancerCare-Canton, Canton
Illinois CancerCare-Carthage, Carthage
외 24개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07388524

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Affiliated Oncologists, LLC, Chicago Ridge
City of Hope® Cancer Center Chicago, Zion

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT06793215

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

University of Chicago Medical Center, Chicago
Endeavor Health, Evanston
Illinois Cancer Care, Peoria

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07361497

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

University of Chicago Hospital, Chicago

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06465069

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

City of Hope, Chicago, Chicago
University of Illinois at Chicago, Chicago
University of Chicago Medical Center, Chicago
외 3개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06890598

A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

Northwestern Medicine - Northwestern Memorial Hospital Galter Pavilion, Chicago

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06706076

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

OSF Saint Anthony's Health Center, Alton
Rush-Copley Medical Center, Aurora
Advocate Outpatient Center - Aurora, Aurora
외 45개

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06418204

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

University of Illinois at Chicago, Chicago
University of Chicago Hospital, Chicago
Springfield Clinic Main Campus, Springfield

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06119581

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

City of Hope Chicago, Zion

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT06667076

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

OSF Saint Anthony's Health Center, Alton
Illinois CancerCare-Bloomington, Bloomington
Illinois CancerCare-Canton, Canton
외 31개

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT03191149

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

OSF Saint Joseph Medical Center, Bloomington
Illinois CancerCare-Bloomington, Bloomington
Illinois CancerCare-Canton, Canton
외 19개

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT07293247

A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.

OSF Saint Francis Medical Center, Peoria

피험자 모집 중2/3상

18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT07365319

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

Illinois Cancer Specialists, Arlington Heights
University of Illinois Hospital and Health Sciences Systems, Chicago

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT07185997

Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations

Northwestern University, Chicago
University of Illinois Hospital and Health Sciences System, Chicago
Duly Health and Care - Lisle, Lisle

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT07195695

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

Local Institution - 007-883-A, Arlington Heights
University of Chicago, Chicago
Loyola University Medical Center, Maywood
외 2개

피험자 모집 중2/3상

18세 이상 · 모든 성별 · 2026. 10. 30. 업데이트됨 · NCT04613596

Study of XB010 in Subjects With Solid Tumors

University of Chicago Medical Center, Chicago

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 10. 30. 업데이트됨 · NCT06545331

Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

University of Chicago, Chicago

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 29. 업데이트됨 · NCT05098132

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Research Site, Chicago
Research Site, Decatur
Research Site, Hinsdale
외 1개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 29. 업데이트됨 · NCT06692738

Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]

University of Chicago Medical Center ( Site 0145), Chicago

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 29. 업데이트됨 · NCT06422143

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Research Site, Hinsdale

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT06357533

Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

Hope And Healing Cancer Services /ID# 276223, Hinsdale

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT06772623

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

Illinois Cancer Specialists, Arlington Heights
University of Illinois at Chicago, Chicago
Springfield Clinic Main Campus, Springfield

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT06875310

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

University of Illinois Cancer Center, Chicago

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 10. 26. 업데이트됨 · NCT06172478

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.